My expertise is blood cancer, specifically multiple myeloma (bone marrow cancer). But I follow therapy innovation for other blood cancers, too; often the same drugs–sometimes in a different combination or with a tweak here or there–work for myeloma, too.
Many of us watched with hopeful wonder as 60 Minutes reported on an innovative biologic solid tumor cancer therapy Sunday evening. But is it as good as it seems?
The New York Times continues to be the best and brightest remaining light for good national journalism. I can’t speak to your politics; I’m impressed with the depth and breadth of the medical writing. I don’t see that as political.
I always knew that chemobrain was real. Years of continuous multiple myeloma (bone marrow cancer) therapy left my mind clouded and me grasping for words during speech that now seemed just out of reach.
If only it could be this easy: using specially designed nano tubes to help diagnose and battle cancer; a twofer!
Looking for an independent, reliable reference site about cancer nutrition? I like this one:
Reading this, I’m reminded of imagining flying cars and jet packs back when I was a kid. How can British scientists arbitrarily pick a date like 2050 for the eradication of cancer?
Its been almost seven years since I was diagnosed with bone marrow cancer. I’ve been receiving ongoing treatment ever since.
Easy to follow explanation for why drug prices are so high in United States as compared to other countries. Here are several excerpts from this important Medscape Today article:
As promised, I’ve been researching the safety and efficacy of enyzme supplements for cancer patients. The news is mixed. From what I’ve been reading they seem relatively safe. But do they help? Or maybe the questions should be, “Help what?”
I saved an article about a timely topic that I wanted to share about the pros and cons of using enzyme supplements.
As usual, my cancer-related tweets this weekend were dominated by fundraising news; walks, runs, dances, silent auctions, celebrity appearances. I also use Google Alerts to help keep me up-to-speed. “Cancer research” category is also dominated by fundraising news. Which got me thinking: Who’s responsibility is it to help cure cancer?
This is exciting news. Not so much because of this specific new drug. But because of what it represents: cancer immunotherapy is becoming a reality.
Ever heard of “canchew?” It’s a hemp based gum that purports to be jam-packed with cancer fighting antioxidants.
There has been a lot cancer related going on in my life.
Are Western medical researchers finally starting to catch up with their Eastern counterparts by using compounds occurring in nature to help cure cancer?
For years I have been preaching that it’s best for cancer patients to avoid antioxidant supplements, especially during chemotherapy. Since many blood cancer patients–like me–seem to be on perpetual therapy, I suggested eating a diet rich in antioxidants and stopping there.
Fasting to regenerate a cancer patient’s immune system? A reader forwarded me the link to this unexpected article about doing just that:
I saved a link to a fascinating Bloomberg article from earlier this month about a backlash against rising drug prices. Here’s an excerpt:
Resveratrol users and advocates had better stop reading now. As with many other hot, designer supplements, looks like Resveratrol may not hold up well once its efficacy is studied using conventional medical methods. Here’s an excerpt. See what you think: